Annexon to present at the raymond james human health innovation conference

South san francisco, calif., june 16, 2021 (globe newswire) -- today,  annexon, inc.  (“annexon”) (nasdaq: annx), a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and neurodegenerative disorders of the body, brain and eye, announced that douglas love, esq., president & chief executive officer, will present at the virtual raymond james human health innovation conference on june 23rd, 2021 at 1:20 pm edt.
ANNX Ratings Summary
ANNX Quant Ranking